Interferon gamma and tumor necrosis factor alpha mRNA expression in mycosis fungoides progression.
Asadullah
K
K
Haeussler
A
A
Sterry
W
W
Döcke
W D
WD
Volk
H D
HD
D054357:Chemokine CXCL10; D019743:Chemokines, CXC; D016001:Confidence Intervals; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis* / Q000172:deficiency / Q000235:genetics; D009182:Mycosis Fungoides / Q000235:genetics* / Q000473:pathology; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics; D016133:Polymerase Chain Reaction / Q000379:methods; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D012334:RNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D012680:Sensitivity and Specificity; D012867:Skin / Q000378:metabolism; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis* / Q000235:genetics
D054357:Chemokine CXCL10; D019743:Chemokines, CXC; D016207:Cytokines; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma